Skip to main content
OpenTrials
Completed

NCT Number: NCT01499927

Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infection as Complication of Medical Care

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Zurich, Center for Clinical Research

Zurich, Canton of Zurich, 8091, Switzerland

About this study

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs, risk of complications as well as higher workload on nursing. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all in-patients in treatment with an intravenous antiinfective for >60h,
  • hospitalized in a ward with computerized physician order entry (cpoe)

Exclusion criteria

  • outpatients,
  • ward without cpoe,
  • no intravenous antiinfective treatment

Treatment and study plan

electronic reminders

Other

Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

Other names: computerized decision support

Primary outcomes

  1. duration of intravenous antiinfective therapy until switching

    Time frame: 1 year

Secondary outcomes

  1. costs (per year, per day and patient)

    Time frame: 1 year

  2. defined daily doses (per 100 days)

    Time frame: 1 year

  3. duration of hospitalization

    Time frame: 1 year

  4. ratio of narrow to broad-spectrum antibiotics

    Time frame: 1 year

  5. requests for consultations

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Acronym: AIR

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Dec 26, 2011
Registry last updated
Dec 19, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.